Loading…
BRD7 suppresses the growth of Nasopharyngeal Carcinoma cells (HNE1) through negatively regulating beta-catenin and ERK pathways
BRD7 is a novel gene which involved NPC in our lab. Our previous studies showed that BRD7 was expressed at high level in normal nasopharyngeal epithelial tissues, but at low level in nasopharyngeal carcinoma biopsies and cell lines. In these papers, we found that ectopic expression of BRD7 can decre...
Saved in:
Published in: | Molecular and cellular biochemistry 2007-09, Vol.303 (1-2), p.141-149 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c327t-7fdddf795b204cdc4e1b594234fa0a5e48d071ae875bf79aebaec0e49f65e5bb3 |
---|---|
cites | cdi_FETCH-LOGICAL-c327t-7fdddf795b204cdc4e1b594234fa0a5e48d071ae875bf79aebaec0e49f65e5bb3 |
container_end_page | 149 |
container_issue | 1-2 |
container_start_page | 141 |
container_title | Molecular and cellular biochemistry |
container_volume | 303 |
creator | Peng, Cong Liu, Hua Ying Zhou, Ming Zhang, Li Ming Li, Xiao Ling Shen, Shou Rong Li, Gui Yuan |
description | BRD7 is a novel gene which involved NPC in our lab. Our previous studies showed that BRD7 was expressed at high level in normal nasopharyngeal epithelial tissues, but at low level in nasopharyngeal carcinoma biopsies and cell lines. In these papers, we found that ectopic expression of BRD7 can decrease cell proliferation and capability to form colonies in soft agar. FCM (Flow cytometry) assay indicated that the cell cycle progression from G1 to S phase was inhibited and the expression of cyclinD1 was significantly decreased after being transfected with BRD7 in HNE1 cells (NPC cells). To further investigate the molecular mechanism of BRD7 suppression of NPC cells growth, the cDNA microarray was performed to detect difference in gene expression profile induced by BRD7. The results indicated that 21 genes expression were changed after being transfected with BRD7 and the differentially expressed gene including alpha-catenin, cyclinD1, E2F3 was confirmed by western-blot. Next, we found that even though no obvious changes of the total expression of beta-catenin were observed, the accumulation of beta-catenin in nucleus was blocked. In addition, it was found that the expression of beta-catenin was up-regulated in the complex composed of beta-catenin and alpha-catenin in HNE1 cells induction of BRD7. So, we concluded that over-expression of BRD7 increased the expression of alpha-catenin which "hold" beta-catenin in the complex and inhibited its accumulating in nucleus. At last, we demonstrated the c-jun, p-MEK, and p-ERK1/2 expression were down-regulated, and the Ap-1 promoter activity was inactive after being transfected with BRD7. We also found that over-expression of BRD7 can inactivate the c-jun and p-ERK1/2 after being treated with EGF in HNE1 cells. These results indicated that BRD7 played a negative role in ERK1/2 pathway. Taken together, our present results provide new insights for BRD7 function to inhibit NPC cells growth through negative regulating beta-catenin and ERK1/2 pathways. |
doi_str_mv | 10.1007/s11010-007-9466-x |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68147255</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2664669500</sourcerecordid><originalsourceid>FETCH-LOGICAL-c327t-7fdddf795b204cdc4e1b594234fa0a5e48d071ae875bf79aebaec0e49f65e5bb3</originalsourceid><addsrcrecordid>eNpdkU9v1DAQxS0EokvhA3BBlpBQObh4EjtOjrBdWtSqSBWco0ky-VNl7dROaPfEV8erXakSp3kj_d5oZh5j70Geg5TmSwCQIEWUolBZJp5esBVokwpVQPGSrWQqpcjBmBP2JoR7GWEJ8JqdgFE615Cv2N9vdxeGh2WaPIVAgc898c67x7nnruW3GNzUo9_ZjnDka_T1YN0WeU3jGPjZ1e0GPkePd0vXc0sdzsMfGnfcU7eMsbEdr2hGUeNMdrAcbcM3d9d8wrl_xF14y161OAZ6d6yn7Pf3za_1lbj5eflj_fVG1GliZmHapmlaU-gqkapuakVQ6UIlqWpRoiaVN9IAUm50FTGkCqmWpIo206SrKj1lnw5zJ-8eFgpzuR3C_gi05JZQZjkok2gdwY__gfdu8TbuViZZFr9caCkjBQeq9i4ET205-WEb_1SCLPfZlIdsyr3cZ1M-Rc-H4-Sl2lLz7DiGkf4D5RaL1g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2664669500</pqid></control><display><type>article</type><title>BRD7 suppresses the growth of Nasopharyngeal Carcinoma cells (HNE1) through negatively regulating beta-catenin and ERK pathways</title><source>Springer Link</source><creator>Peng, Cong ; Liu, Hua Ying ; Zhou, Ming ; Zhang, Li Ming ; Li, Xiao Ling ; Shen, Shou Rong ; Li, Gui Yuan</creator><creatorcontrib>Peng, Cong ; Liu, Hua Ying ; Zhou, Ming ; Zhang, Li Ming ; Li, Xiao Ling ; Shen, Shou Rong ; Li, Gui Yuan</creatorcontrib><description>BRD7 is a novel gene which involved NPC in our lab. Our previous studies showed that BRD7 was expressed at high level in normal nasopharyngeal epithelial tissues, but at low level in nasopharyngeal carcinoma biopsies and cell lines. In these papers, we found that ectopic expression of BRD7 can decrease cell proliferation and capability to form colonies in soft agar. FCM (Flow cytometry) assay indicated that the cell cycle progression from G1 to S phase was inhibited and the expression of cyclinD1 was significantly decreased after being transfected with BRD7 in HNE1 cells (NPC cells). To further investigate the molecular mechanism of BRD7 suppression of NPC cells growth, the cDNA microarray was performed to detect difference in gene expression profile induced by BRD7. The results indicated that 21 genes expression were changed after being transfected with BRD7 and the differentially expressed gene including alpha-catenin, cyclinD1, E2F3 was confirmed by western-blot. Next, we found that even though no obvious changes of the total expression of beta-catenin were observed, the accumulation of beta-catenin in nucleus was blocked. In addition, it was found that the expression of beta-catenin was up-regulated in the complex composed of beta-catenin and alpha-catenin in HNE1 cells induction of BRD7. So, we concluded that over-expression of BRD7 increased the expression of alpha-catenin which "hold" beta-catenin in the complex and inhibited its accumulating in nucleus. At last, we demonstrated the c-jun, p-MEK, and p-ERK1/2 expression were down-regulated, and the Ap-1 promoter activity was inactive after being transfected with BRD7. We also found that over-expression of BRD7 can inactivate the c-jun and p-ERK1/2 after being treated with EGF in HNE1 cells. These results indicated that BRD7 played a negative role in ERK1/2 pathway. Taken together, our present results provide new insights for BRD7 function to inhibit NPC cells growth through negative regulating beta-catenin and ERK1/2 pathways.</description><identifier>ISSN: 0300-8177</identifier><identifier>EISSN: 1573-4919</identifier><identifier>DOI: 10.1007/s11010-007-9466-x</identifier><identifier>PMID: 17458518</identifier><language>eng</language><publisher>Netherlands: Springer Nature B.V</publisher><subject>Accumulation ; beta Catenin - genetics ; beta Catenin - metabolism ; Biopsy ; c-Jun protein ; Cell Cycle ; Cell Nucleus - metabolism ; Cell Proliferation ; Chromosomal Proteins, Non-Histone - physiology ; Cyclin D1 - metabolism ; DNA microarrays ; Ectopic expression ; Extracellular signal-regulated kinase ; Flow cytometry ; Gene expression ; Gene Expression Profiling ; Gene Expression Regulation, Neoplastic ; Humans ; Immunoprecipitation ; Low level ; Metabolic pathways ; Mitogen-Activated Protein Kinase 1 - metabolism ; Mitogen-Activated Protein Kinase 3 - metabolism ; Molecular Sequence Data ; Nasopharyngeal carcinoma ; Nasopharyngeal Neoplasms - genetics ; Nasopharyngeal Neoplasms - metabolism ; Nasopharyngeal Neoplasms - pathology ; Nuclear Proteins - physiology ; Nuclei (cytology) ; Oligonucleotide Array Sequence Analysis ; Overexpression ; S phase ; Signal Transduction ; Throat cancer ; Transcription factors ; Transcription, Genetic ; Tumor cell lines ; Tumor Cells, Cultured ; α-Catenin ; β-Catenin</subject><ispartof>Molecular and cellular biochemistry, 2007-09, Vol.303 (1-2), p.141-149</ispartof><rights>Springer Science+Business Media, LLC 2007.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c327t-7fdddf795b204cdc4e1b594234fa0a5e48d071ae875bf79aebaec0e49f65e5bb3</citedby><cites>FETCH-LOGICAL-c327t-7fdddf795b204cdc4e1b594234fa0a5e48d071ae875bf79aebaec0e49f65e5bb3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17458518$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Peng, Cong</creatorcontrib><creatorcontrib>Liu, Hua Ying</creatorcontrib><creatorcontrib>Zhou, Ming</creatorcontrib><creatorcontrib>Zhang, Li Ming</creatorcontrib><creatorcontrib>Li, Xiao Ling</creatorcontrib><creatorcontrib>Shen, Shou Rong</creatorcontrib><creatorcontrib>Li, Gui Yuan</creatorcontrib><title>BRD7 suppresses the growth of Nasopharyngeal Carcinoma cells (HNE1) through negatively regulating beta-catenin and ERK pathways</title><title>Molecular and cellular biochemistry</title><addtitle>Mol Cell Biochem</addtitle><description>BRD7 is a novel gene which involved NPC in our lab. Our previous studies showed that BRD7 was expressed at high level in normal nasopharyngeal epithelial tissues, but at low level in nasopharyngeal carcinoma biopsies and cell lines. In these papers, we found that ectopic expression of BRD7 can decrease cell proliferation and capability to form colonies in soft agar. FCM (Flow cytometry) assay indicated that the cell cycle progression from G1 to S phase was inhibited and the expression of cyclinD1 was significantly decreased after being transfected with BRD7 in HNE1 cells (NPC cells). To further investigate the molecular mechanism of BRD7 suppression of NPC cells growth, the cDNA microarray was performed to detect difference in gene expression profile induced by BRD7. The results indicated that 21 genes expression were changed after being transfected with BRD7 and the differentially expressed gene including alpha-catenin, cyclinD1, E2F3 was confirmed by western-blot. Next, we found that even though no obvious changes of the total expression of beta-catenin were observed, the accumulation of beta-catenin in nucleus was blocked. In addition, it was found that the expression of beta-catenin was up-regulated in the complex composed of beta-catenin and alpha-catenin in HNE1 cells induction of BRD7. So, we concluded that over-expression of BRD7 increased the expression of alpha-catenin which "hold" beta-catenin in the complex and inhibited its accumulating in nucleus. At last, we demonstrated the c-jun, p-MEK, and p-ERK1/2 expression were down-regulated, and the Ap-1 promoter activity was inactive after being transfected with BRD7. We also found that over-expression of BRD7 can inactivate the c-jun and p-ERK1/2 after being treated with EGF in HNE1 cells. These results indicated that BRD7 played a negative role in ERK1/2 pathway. Taken together, our present results provide new insights for BRD7 function to inhibit NPC cells growth through negative regulating beta-catenin and ERK1/2 pathways.</description><subject>Accumulation</subject><subject>beta Catenin - genetics</subject><subject>beta Catenin - metabolism</subject><subject>Biopsy</subject><subject>c-Jun protein</subject><subject>Cell Cycle</subject><subject>Cell Nucleus - metabolism</subject><subject>Cell Proliferation</subject><subject>Chromosomal Proteins, Non-Histone - physiology</subject><subject>Cyclin D1 - metabolism</subject><subject>DNA microarrays</subject><subject>Ectopic expression</subject><subject>Extracellular signal-regulated kinase</subject><subject>Flow cytometry</subject><subject>Gene expression</subject><subject>Gene Expression Profiling</subject><subject>Gene Expression Regulation, Neoplastic</subject><subject>Humans</subject><subject>Immunoprecipitation</subject><subject>Low level</subject><subject>Metabolic pathways</subject><subject>Mitogen-Activated Protein Kinase 1 - metabolism</subject><subject>Mitogen-Activated Protein Kinase 3 - metabolism</subject><subject>Molecular Sequence Data</subject><subject>Nasopharyngeal carcinoma</subject><subject>Nasopharyngeal Neoplasms - genetics</subject><subject>Nasopharyngeal Neoplasms - metabolism</subject><subject>Nasopharyngeal Neoplasms - pathology</subject><subject>Nuclear Proteins - physiology</subject><subject>Nuclei (cytology)</subject><subject>Oligonucleotide Array Sequence Analysis</subject><subject>Overexpression</subject><subject>S phase</subject><subject>Signal Transduction</subject><subject>Throat cancer</subject><subject>Transcription factors</subject><subject>Transcription, Genetic</subject><subject>Tumor cell lines</subject><subject>Tumor Cells, Cultured</subject><subject>α-Catenin</subject><subject>β-Catenin</subject><issn>0300-8177</issn><issn>1573-4919</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><recordid>eNpdkU9v1DAQxS0EokvhA3BBlpBQObh4EjtOjrBdWtSqSBWco0ky-VNl7dROaPfEV8erXakSp3kj_d5oZh5j70Geg5TmSwCQIEWUolBZJp5esBVokwpVQPGSrWQqpcjBmBP2JoR7GWEJ8JqdgFE615Cv2N9vdxeGh2WaPIVAgc898c67x7nnruW3GNzUo9_ZjnDka_T1YN0WeU3jGPjZ1e0GPkePd0vXc0sdzsMfGnfcU7eMsbEdr2hGUeNMdrAcbcM3d9d8wrl_xF14y161OAZ6d6yn7Pf3za_1lbj5eflj_fVG1GliZmHapmlaU-gqkapuakVQ6UIlqWpRoiaVN9IAUm50FTGkCqmWpIo206SrKj1lnw5zJ-8eFgpzuR3C_gi05JZQZjkok2gdwY__gfdu8TbuViZZFr9caCkjBQeq9i4ET205-WEb_1SCLPfZlIdsyr3cZ1M-Rc-H4-Sl2lLz7DiGkf4D5RaL1g</recordid><startdate>200709</startdate><enddate>200709</enddate><creator>Peng, Cong</creator><creator>Liu, Hua Ying</creator><creator>Zhou, Ming</creator><creator>Zhang, Li Ming</creator><creator>Li, Xiao Ling</creator><creator>Shen, Shou Rong</creator><creator>Li, Gui Yuan</creator><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7QP</scope><scope>7T5</scope><scope>7T7</scope><scope>7TK</scope><scope>7TM</scope><scope>7TO</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7N</scope><scope>M7P</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>200709</creationdate><title>BRD7 suppresses the growth of Nasopharyngeal Carcinoma cells (HNE1) through negatively regulating beta-catenin and ERK pathways</title><author>Peng, Cong ; Liu, Hua Ying ; Zhou, Ming ; Zhang, Li Ming ; Li, Xiao Ling ; Shen, Shou Rong ; Li, Gui Yuan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c327t-7fdddf795b204cdc4e1b594234fa0a5e48d071ae875bf79aebaec0e49f65e5bb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Accumulation</topic><topic>beta Catenin - genetics</topic><topic>beta Catenin - metabolism</topic><topic>Biopsy</topic><topic>c-Jun protein</topic><topic>Cell Cycle</topic><topic>Cell Nucleus - metabolism</topic><topic>Cell Proliferation</topic><topic>Chromosomal Proteins, Non-Histone - physiology</topic><topic>Cyclin D1 - metabolism</topic><topic>DNA microarrays</topic><topic>Ectopic expression</topic><topic>Extracellular signal-regulated kinase</topic><topic>Flow cytometry</topic><topic>Gene expression</topic><topic>Gene Expression Profiling</topic><topic>Gene Expression Regulation, Neoplastic</topic><topic>Humans</topic><topic>Immunoprecipitation</topic><topic>Low level</topic><topic>Metabolic pathways</topic><topic>Mitogen-Activated Protein Kinase 1 - metabolism</topic><topic>Mitogen-Activated Protein Kinase 3 - metabolism</topic><topic>Molecular Sequence Data</topic><topic>Nasopharyngeal carcinoma</topic><topic>Nasopharyngeal Neoplasms - genetics</topic><topic>Nasopharyngeal Neoplasms - metabolism</topic><topic>Nasopharyngeal Neoplasms - pathology</topic><topic>Nuclear Proteins - physiology</topic><topic>Nuclei (cytology)</topic><topic>Oligonucleotide Array Sequence Analysis</topic><topic>Overexpression</topic><topic>S phase</topic><topic>Signal Transduction</topic><topic>Throat cancer</topic><topic>Transcription factors</topic><topic>Transcription, Genetic</topic><topic>Tumor cell lines</topic><topic>Tumor Cells, Cultured</topic><topic>α-Catenin</topic><topic>β-Catenin</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Peng, Cong</creatorcontrib><creatorcontrib>Liu, Hua Ying</creatorcontrib><creatorcontrib>Zhou, Ming</creatorcontrib><creatorcontrib>Zhang, Li Ming</creatorcontrib><creatorcontrib>Li, Xiao Ling</creatorcontrib><creatorcontrib>Shen, Shou Rong</creatorcontrib><creatorcontrib>Li, Gui Yuan</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Immunology Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health Medical collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Biological Sciences</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest Science Journals</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Molecular and cellular biochemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Peng, Cong</au><au>Liu, Hua Ying</au><au>Zhou, Ming</au><au>Zhang, Li Ming</au><au>Li, Xiao Ling</au><au>Shen, Shou Rong</au><au>Li, Gui Yuan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>BRD7 suppresses the growth of Nasopharyngeal Carcinoma cells (HNE1) through negatively regulating beta-catenin and ERK pathways</atitle><jtitle>Molecular and cellular biochemistry</jtitle><addtitle>Mol Cell Biochem</addtitle><date>2007-09</date><risdate>2007</risdate><volume>303</volume><issue>1-2</issue><spage>141</spage><epage>149</epage><pages>141-149</pages><issn>0300-8177</issn><eissn>1573-4919</eissn><abstract>BRD7 is a novel gene which involved NPC in our lab. Our previous studies showed that BRD7 was expressed at high level in normal nasopharyngeal epithelial tissues, but at low level in nasopharyngeal carcinoma biopsies and cell lines. In these papers, we found that ectopic expression of BRD7 can decrease cell proliferation and capability to form colonies in soft agar. FCM (Flow cytometry) assay indicated that the cell cycle progression from G1 to S phase was inhibited and the expression of cyclinD1 was significantly decreased after being transfected with BRD7 in HNE1 cells (NPC cells). To further investigate the molecular mechanism of BRD7 suppression of NPC cells growth, the cDNA microarray was performed to detect difference in gene expression profile induced by BRD7. The results indicated that 21 genes expression were changed after being transfected with BRD7 and the differentially expressed gene including alpha-catenin, cyclinD1, E2F3 was confirmed by western-blot. Next, we found that even though no obvious changes of the total expression of beta-catenin were observed, the accumulation of beta-catenin in nucleus was blocked. In addition, it was found that the expression of beta-catenin was up-regulated in the complex composed of beta-catenin and alpha-catenin in HNE1 cells induction of BRD7. So, we concluded that over-expression of BRD7 increased the expression of alpha-catenin which "hold" beta-catenin in the complex and inhibited its accumulating in nucleus. At last, we demonstrated the c-jun, p-MEK, and p-ERK1/2 expression were down-regulated, and the Ap-1 promoter activity was inactive after being transfected with BRD7. We also found that over-expression of BRD7 can inactivate the c-jun and p-ERK1/2 after being treated with EGF in HNE1 cells. These results indicated that BRD7 played a negative role in ERK1/2 pathway. Taken together, our present results provide new insights for BRD7 function to inhibit NPC cells growth through negative regulating beta-catenin and ERK1/2 pathways.</abstract><cop>Netherlands</cop><pub>Springer Nature B.V</pub><pmid>17458518</pmid><doi>10.1007/s11010-007-9466-x</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0300-8177 |
ispartof | Molecular and cellular biochemistry, 2007-09, Vol.303 (1-2), p.141-149 |
issn | 0300-8177 1573-4919 |
language | eng |
recordid | cdi_proquest_miscellaneous_68147255 |
source | Springer Link |
subjects | Accumulation beta Catenin - genetics beta Catenin - metabolism Biopsy c-Jun protein Cell Cycle Cell Nucleus - metabolism Cell Proliferation Chromosomal Proteins, Non-Histone - physiology Cyclin D1 - metabolism DNA microarrays Ectopic expression Extracellular signal-regulated kinase Flow cytometry Gene expression Gene Expression Profiling Gene Expression Regulation, Neoplastic Humans Immunoprecipitation Low level Metabolic pathways Mitogen-Activated Protein Kinase 1 - metabolism Mitogen-Activated Protein Kinase 3 - metabolism Molecular Sequence Data Nasopharyngeal carcinoma Nasopharyngeal Neoplasms - genetics Nasopharyngeal Neoplasms - metabolism Nasopharyngeal Neoplasms - pathology Nuclear Proteins - physiology Nuclei (cytology) Oligonucleotide Array Sequence Analysis Overexpression S phase Signal Transduction Throat cancer Transcription factors Transcription, Genetic Tumor cell lines Tumor Cells, Cultured α-Catenin β-Catenin |
title | BRD7 suppresses the growth of Nasopharyngeal Carcinoma cells (HNE1) through negatively regulating beta-catenin and ERK pathways |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T12%3A06%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=BRD7%20suppresses%20the%20growth%20of%20Nasopharyngeal%20Carcinoma%20cells%20(HNE1)%20through%20negatively%20regulating%20beta-catenin%20and%20ERK%20pathways&rft.jtitle=Molecular%20and%20cellular%20biochemistry&rft.au=Peng,%20Cong&rft.date=2007-09&rft.volume=303&rft.issue=1-2&rft.spage=141&rft.epage=149&rft.pages=141-149&rft.issn=0300-8177&rft.eissn=1573-4919&rft_id=info:doi/10.1007/s11010-007-9466-x&rft_dat=%3Cproquest_cross%3E2664669500%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c327t-7fdddf795b204cdc4e1b594234fa0a5e48d071ae875bf79aebaec0e49f65e5bb3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2664669500&rft_id=info:pmid/17458518&rfr_iscdi=true |